Three kinds of drug-eluting bead transarterial chemoembolisation for treating patients with unresectable non-small cell lung cancer

Figure 2 A 78-year-old man with advanced squamous cell carcinoma treated using drug-eluting bead transarterial chemoembolization in the doxorubicin group. A: Bone scintigraphy examination revealed a left rib metastasis; B: Chest computerized tomography examination revealed a malignant tumour in the left lung (asterisk); C: The left bronchial artery was catheterised, and the blood-supplying artery was embolised using doxorubicin-eluting beads; D: The left lung tumour (asterisk) was found to shrink at the 16-month follow-up, and this man died of tumour progression after 7 months.